PROMise: Investigation into the combination of a Plexxikon BETi with ruxolitinib in patients with high or intermediate-2 risk myelofibrosis not recieving an adequate respnse with ruxolitinib alone (Adam Mead)

  • Craddock, Charles (Principal Investigator)
  • Fox, Sonia (Co-Investigator)
  • Boucher, Becky (Researcher)

Project Details

Short titlePROMise: Investigation into the combination of a Plexxikon BETi with ruxolitinib in patients with high or intermediate-2 risk myelofibrosis not recieving an adequate respnse with ruxolitinib alone (Adam Mead)
StatusActive
Effective start/end date1/05/19 → 30/04/24

Funding

  • PLEXXIKON INC
  • Cancer Research Uk